Next Digital Health

What is Master Data Management? Its Impact and Importance in Healthcare - Next Digital Health

How Advanced RFID in Health Care Enhance Patient Safety and Workflow - Next Digital Health

Europe is facing a measles outbreak, WHO says - Next Digital Health

My Memo is a automatic pill dispenser with some ‘pill-zazz’ - Next Digital Health

Eli Lily is under investigation by FDA for manufacturing lapses in its plant - Next Digital Health

Here is the full review of Aktiia Bracelet in 2024. Find out if it is the right blood pressure monitoring solution for your needs or not!

Here is a list of 10 must-have gadgets that doctors must carry in their pockets/briefcase in 2024.

Here is a list of the 10 best dermatological apps for your skin care in 2024 that have been tested and found out to be accurate by our team at NextDigitalHealth

Early Death risk linked with use of Erectile Dysfunction and Chest Pain Medications: Study - Next Digital Health

HerMD "offers comprehensive women’s healthcare, in-person or virtual, and one of its differentiators is that the average appointment is between 20 and 60 minutes". HerMD also offers cosmetic treatments such as facial injectables and body treatments, one of its differentiating factors. The company just raised $18M and plans to open a new women's health clinic.

Varda Space Industries, a pioneering space startup founded in 2021 by Delian Asparouhov and Will Bruey, has achieved a significant milestone with the closure of a $90 million Series B funding round. This development comes shortly after the successful return of their inaugural drug manufacturing capsule from orbit. The funding infusion signifies a pivotal moment

restor3d, a North Carolina Orthopedic care tech startup specializing in developing personalized 3D-printed orthopedic implants, has secured $70M financing to accelerate its growth and innovation and maximize patients’ outcomes.

UK-based Medtech startup Amber Therapeutics has announced the successful closing of its series A financing round, securing $100 million to advance Amber-UI, a breakthrough therapy for women suffering from mixed urinary incontinence (MUI). The financing, which is one of Europe’s series A rounds for a medical technology company, featured participation from leading healthcare and tech Amber Therapeutics will use the latest investment to advance pivotal clinical studies of Amber-UI for FDA approval.

Grayce, a California-based health tech startup providing a comprehensive social care management platform for social workers, has secured $10.4M in a Series A funding round to advance family care solutions. The funding round was led by Maveron, with participation from leading healthcare investors, including BBG Ventures, Correlation Ventures, Alumni Ventures, GingerBread Capital, Visible Ventures, What Grayce will use the new capital to advance family care solutions and its social care management platform.

Phoenix-based software-as-a-medical device startup Mindset Medical, Inc. has secured $8M in series A financing round to further develop its digital health solutions, Informed Vital Core, a non-contact physiological measurements application for healthcare professionals.

A Clinician-founded generative AI company that simplifies administrative work for healthcare professionals, Anterior (formerly Co: Helm), has secured $20M in series A financing. The company will use the new capital to accelerate hiring and product development, making the prior authorization process seamless for healthcare payers.

A California-based precision immunology company, Santa Ana Bio, has emerged from stealth with a combined series A and B funding of $168 to deliver precision medicines for patients struggling with inflammatory diseases.

Enveda Biosciences, a Colorado-based biotech company that leverages the power of AI to develop new plant-based medicines, has secured $55M in a series B2 financing round to advance its breakthrough AI-powered drug discovery platform.

Vico Therapeutics B.V, a clinical-stage genetic medicines company focusing on the development of novel therapies for severe neurological illnesses, has secured €65.8 million ($70.7 million) in Series B financing to advance lead clinical programs, Seroba announced on Monday, June 24, 2024.

OCON Therapeutics, an Israeli pioneer of intrauterine drug-delivery technology for treating severe uterine conditions, has secured $10m in funding to revolutionize drug delivery capabilities. Led by CEO Keren Leshem, the company’s latest funding round was spearheaded by RH Capital, with a significant contribution from Features Capital, Exerte Partners, and Astia Angels. According to OCON Therapeutics